ASHR vs XBI
Xtrackers Harvest CSI 300 China A-Shares ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.65% for ASHR.
- • ASHR pays a higher dividend yield (2.07%).
Side-by-side metrics
| Metric | ASHR | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.65% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.07% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $1.64B | $10.73B |
YTD return | 6.06% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.68 | 1.10 |
P/E ratio | 17.23 | — |
Last price | $35.88 | $164.28 |
Inception | — | — |
Issuer | Xtrackers | State Street |
ASHR top holdings
| 300308.SZ | Zhongji Innolight Co Ltd Class A | 4.80% |
| 300750.SZ | Contemporary Amperex Technology Co Ltd Class A | 3.53% |
| 300502.SZ | Eoptolink Technology Inc Ltd Class A | 2.88% |
| 600519.SS | Kweichow Moutai Co Ltd Class A | 2.51% |
| 603986.SS | GigaDevice Semiconductor Inc Class A | 1.87% |
| 601318.SS | Ping An Insurance (Group) Co. of China Ltd Class A | 1.72% |
| 688256.SS | Cambricon Technologies Corp Ltd Class A | 1.71% |
| 600036.SS | China Merchants Bank Co Ltd Class A | 1.50% |
| 601899.SS | Zijin Mining Group Co Ltd Class A | 1.42% |
| 002371.SZ | NAURA Technology Group Co Ltd Class A | 1.35% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About ASHR
ASHR (Xtrackers Harvest CSI 300 China A-Shares ETF) is China A-shares listed on Shanghai and Shenzhen exchanges. Managed by Xtrackers, the fund carries $1.6B in assets under management, an expense ratio of 0.65%, a dividend yield of 2.07%. Its largest holding is Zhongji Innolight Co Ltd Class A (300308.SZ), which represents 4.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.3%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.